TLR4 antagonism provides short-term but not long-term clinical benefit in a full-depth cartilage defect mouse model

References

• Brown TD, Johnston RC, Saltzman CL, Marsh JL, Buckwalter JA. Posttraumatic osteoarthritis: a first estimate of incidence, prevalence, and burden of disease. J Orthop Trauma. 2006;20(10):739–744. doi:10.1097/01.bot.0000246468.80635.ef.
   PubMed Web of Science ®Google Scholar
• Thomas AC, Hubbard-Turner T, Wikstrom EA, Palmieri-Smith RM. Epidemiology of Posttraumatic osteoarthritis. J Athl Train. 2017;52(6):491–496. doi:10.4085/1062-6050-51.5.08.
   PubMed Web of Science ®Google Scholar
• Muthuri SG, McWilliams DF, Doherty M, Zhang W. History of knee injuries and knee osteoarthritis: a meta-analysis of observational studies. Osteoarthritis And Cartilage. 2011;19(11):1286–1293. doi:10.1016/j.joca.2011.07.015.
   PubMed Web of Science ®Google Scholar
• March L, Smith EU, Hoy DG, Cross MJ, Sanchez-Riera L, Blyth F, Buchbinder R, Vos T, Woolf AD. Burden of disability due to musculoskeletal (MSK) disorders. Best Pract Res Clin Rheumatol. 2014;28(3):353–366. doi:10.1016/j.berh.2014.08.002.
   PubMed Web of Science ®Google Scholar
• Turkiewicz A, Kiadaliri AA, Englund M. Cause-specific mortality in osteoarthritis of peripheral joints. Osteoarthritis And Cartilage. 2019;27(6):848–854. doi:10.1016/j.joca.2019.02.793.
   PubMed Web of Science ®Google Scholar
• Stolberg-Stolberg J, Boettcher A, Sambale M, Stuecker S, Sherwood J, Raschke M, Pap T, Bertrand J. Toll-like receptor 3 activation promotes joint degeneration in osteoarthritis. Cell Death Disease. 2022;13(3):224. doi:10.1038/s41419-022-04680-5.
   PubMed Web of Science ®Google Scholar
• Barreto G, Manninen M, Eklund K. Osteoarthritis and toll-like receptors: when innate immunity meets chondrocyte apoptosis. Biology (Basel). 2020;9(4). doi:10.3390/biology9040065.
   PubMedGoogle Scholar
• Chen GY, Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010;10(12):826–837. doi:10.1038/nri2873.
   PubMed Web of Science ®Google Scholar
• Chang EJ, Kim HJ, Ha J, Ryu J, Park KH, Kim UH, Lee ZH, Kim HM, Fisher DE, Kim HH. Hyaluronan inhibits osteoclast differentiation via toll-like receptor 4. J Cell Sci. 2007;120(Pt 1):166–176. doi:10.1242/jcs.03310.
   PubMed Web of Science ®Google Scholar
• Gómez R, Villalvilla A, Largo R, Gualillo O, Herrero-Beaumont G. TLR4 signalling in osteoarthritis–finding targets for candidate DMOADs. Nat Rev Rheumatol. 2015;11(3):159–170. doi:10.1038/nrrheum.2014.209.
   PubMed Web of Science ®Google Scholar
• Gangloff M. Different dimerisation mode for TLR4 upon endosomal acidification? Trends Biochem Sci. 2012;37(3):92–98. doi:10.1016/j.tibs.2011.11.003.
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4(7):499–511. doi:10.1038/nri1391.
   PubMed Web of Science ®Google Scholar
• Takeda K, Akira S. TLR signaling pathways. Semin Immunol. 2004;16(1):3–9. doi:10.1016/j.smim.2003.10.003.
   PubMed Web of Science ®Google Scholar
• Juarranz Y, Gutiérrez-Cañas I, Arranz A, Martínez C, Abad C, Leceta J, Pablos JL, Gomariz RP. VIP decreases TLR4 expression induced by LPS and TNF-α treatment in human synovial fibroblasts. Ann N Y Acad Sci. 2006;1070(1):359–364. doi:10.1196/annals.1317.045.
   PubMedGoogle Scholar
• Midwood K, Sacre S, Piccinini AM, Inglis J, Trebaul A, Chan E, Drexler S, Sofat N, Kashiwagi M, Orend G, others. Tenascin-C is an endogenous activator of toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med. 2009;15(7):774–780. doi:10.1038/nm.1987.
   PubMed Web of Science ®Google Scholar
• Nair A, Kanda V, Bush-Joseph C, Verma N, Chubinskaya S, Mikecz K, Glant TT, Malfait AM, Crow MK, Spear GT, others. Synovial fluid from patients with early osteoarthritis modulates fibroblast-like synoviocyte responses to toll-like receptor 4 and toll-like receptor 2 ligands via soluble CD14. Arthritis & Rheumatism. 2012;64(7):2268–2277. doi:10.1002/art.34495.
   PubMed Web of Science ®Google Scholar
• Medzhitov R, Preston-Hurlburt P, Janeway CA. A human homologue of the drosophila toll protein signals activation of adaptive immunity. Nature. 1997;388(6640):394–397. doi:10.1038/41131.
   PubMed Web of Science ®Google Scholar
• Wang P, Zhu F, Tong Z, Konstantopoulos K. Response of chondrocytes to shear stress: antagonistic effects of the binding partners toll-like receptor 4 and caveolin-1. FASEB J. 2011;25(10):3401–3415. doi:10.1096/fj.11-184861.
   PubMed Web of Science ®Google Scholar
• Kikuchi T, Matsuguchi T, Tsuboi N, Mitani A, Tanaka S, Matsuoka M, Yamamoto G, Hishikawa T, Noguchi T, Yoshikai Y. Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via toll-like receptors. J Immunol. 2001;166(5):3574–3579. doi:10.4049/jimmunol.166.5.3574.
   PubMed Web of Science ®Google Scholar
• Tamaki Y, Takakubo Y, Hirayama T, Konttinen YT, Goodman SB, Yamakawa M, Takagi M. Expression of toll-like receptors and their signaling pathways in rheumatoid synovitis. J Rheumatol. 2011;38(5):810–820. doi:10.3899/jrheum.100732.
   PubMed Web of Science ®Google Scholar
• Ospelt C, Brentano F, Rengel Y, Stanczyk J, Kolling C, Tak PP, Gay RE, Gay S, Kyburz D. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis. Arthritis & Rheumatism. 2008;58(12):3684–3692. doi:10.1002/art.24140.
   PubMed Web of Science ®Google Scholar
• Ayral X, Pickering EH, Woodworth TG, Mackillop N, Dougados M. Synovitis: a potential predictive factor of structural progression of medial tibiofemoral knee osteoarthritis – results of a 1 year longitudinal arthroscopic study in 422 patients. Osteoarthritis And Cartilage. 2005;13(5):361–367. doi:10.1016/j.joca.2005.01.005.
   PubMed Web of Science ®Google Scholar
• Schelbergen RF, Blom AB, van den Bosch MH, Slöetjes A, Abdollahi-Roodsaz S, Schreurs BW, Mort JS, Vogl T, Roth J, van den Berg WB, others. Alarmins S100A8 and S100A9 elicit a catabolic effect in human osteoarthritic chondrocytes that is dependent on toll-like receptor 4. Arthritis & Rheumatism. 2012;64(5):1477–1487. doi:10.1002/art.33495.
   PubMed Web of Science ®Google Scholar
• Karlsson C, Dehne T, Lindahl A, Brittberg M, Pruss A, Sittinger M, Ringe J. Genome-wide expression profiling reveals new candidate genes associated with osteoarthritis. Osteoarthritis And Cartilage. 2010;18(4):581–592. doi:10.1016/j.joca.2009.12.002.
   PubMed Web of Science ®Google Scholar
• Kim HA, Cho ML, Choi HY, Yoon CS, Jhun JY, Oh HJ, Kim HY. The catabolic pathway mediated by toll-like receptors in human osteoarthritic chondrocytes. Arthritis & Rheumatism. 2006;54(7):2152–2163. doi:10.1002/art.21951.
   PubMed Web of Science ®Google Scholar
• Eltawil NM, De Bari C, Achan P, Pitzalis C, Dell’accio F. A novel in vivo murine model of cartilage regeneration. Age And Strain-Dependent Outcome After Joint Surface Injury Osteoarthritis Cartilage. 2009;17(6):695–704. doi:10.1016/j.joca.2008.11.003.
   Google Scholar
• Ferreira-Gomes J, Garcia MM, Nascimento D, Almeida L, Quesada E, Castro-Lopes JM, Pascual D, Goicoechea C, Neto FL. TLR4 antagonism reduces movement-induced nociception and ATF-3 expression in experimental osteoarthritis. J Pain Res. 2021;14:2615–2627. doi:10.2147/JPR.S317877.
   PubMed Web of Science ®Google Scholar
• Krock E, Millecamps M, Currie JB, Stone LS, Haglund L. Low back pain and disc degeneration are decreased following chronic toll-like receptor 4 inhibition in a mouse model. Osteoarthritis And Cartilage. 2018;26(9):1236–1246. doi:10.1016/j.joca.2018.06.002.
   PubMed Web of Science ®Google Scholar
• Nasi S, Ea HK, Chobaz V, van Lent P, Lioté F, So A, Busso N. Dispensable role of myeloid differentiation primary response gene 88 (MyD88) and MyD88-dependent toll-like receptors (TLRs) in a murine model of osteoarthritis. Joint Bone Spine. 2014;81(4):320–324. doi:10.1016/j.jbspin.2014.01.018.
   PubMed Web of Science ®Google Scholar
• Miller RE, Belmadani A, Ishihara S, Tran PB, Ren D, Miller RJ, Malfait AM. Damage-associated molecular patterns generated in osteoarthritis directly excite murine nociceptive neurons through toll-like receptor 4. Arthritis Rheumatol. 2015;67(11):2933–2943. doi:10.1002/art.39291.
   PubMed Web of Science ®Google Scholar
• Liu X, Cai HX, Cao PY, Feng Y, Jiang HH, Liu L, Ke J, Long X. TLR4 contributes to the damage of cartilage and subchondral bone in discectomy-induced TMJOA mice. J Cell Mol Med. 2020;24(19):11489–11499. doi:10.1111/jcmm.15763.
   PubMed Web of Science ®Google Scholar
• Baker PJ, Taylor CE, Stashak PW, Fauntleroy MB, Hasløv K, Qureshi N, Takayama K. Inactivation of suppressor T cell activity by the nontoxic lipopolysaccharide of rhodopseudomonas sphaeroides. Infect Immun. 1990;58(9):2862–2868. doi:10.1128/iai.58.9.2862-2868.1990.
   PubMed Web of Science ®Google Scholar
• Lu Z, Zhang X, Li Y, Lopes-Virella MF, Huang Y. TLR4 antagonist attenuates atherogenesis in LDL receptor-deficient mice with diet-induced type 2 diabetes. Immunobiology. 2015;220(11):1246–1254. doi:10.1016/j.imbio.2015.06.016.
   PubMed Web of Science ®Google Scholar
• Frisbie DD, Kawcak CE, Trotter GW, Powers BE, Walton RM, McIlwraith CW. Effects of triamcinolone acetonide on an in vivo equine osteochondral fragment exercise model. Equine Vet J. 1997;29(5):349–359. doi:10.1111/j.2042-3306.1997.tb03138.x.
   PubMed Web of Science ®Google Scholar
• Hirschfeld M, Ma Y, Weis JH, Vogel SN, Weis JJ. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol. 2000;165(2):618–622. doi:10.4049/jimmunol.165.2.618.
   PubMed Web of Science ®Google Scholar
• Plaas A, Li J, Riesco J, Das R, Sandy JD, Harrison A. Intraarticular injection of hyaluronan prevents cartilage erosion, periarticular fibrosis and mechanical allodynia and normalizes stance time in murine knee osteoarthritis. Arthritis Res Ther. 2011;13(2):R46. doi:10.1186/ar3286.
   PubMed Web of Science ®Google Scholar
• Ferreira-Gomes J, Adães S, Mendonça M, Castro-Lopes JM. Analgesic effects of lidocaine, morphine and diclofenac on movement-induced nociception, as assessed by the knee-bend and CatWalk tests in a rat model of osteoarthritis. Pharmacol Biochem Behav. 2012;101(4):617–624. doi:10.1016/j.pbb.2012.03.003.
   PubMed Web of Science ®Google Scholar
• van der Sluijs JA, Geesink RG, van der Linden AJ, Bulstra SK, Kuyer R, Drukker J. The reliability of the Mankin score for osteoarthritis. J Orthop Res. 1992;10(1):58–61. doi:10.1002/jor.1100100107.
   PubMed Web of Science ®Google Scholar
• Longobardi L, Temple JD, Tagliafierro L, Willcockson H, Esposito A, D’Onofrio N, Stein E, Li T, Myers TJ, Ozkan H, Balestrieri ML, Ulici V, Loeser RF, Spagnoli A. Ozkan H and others. Role of the C-C chemokine receptor-2 in a murine model of injury-induced osteoarthritis. Osteoarthritis And Cartilage. 2017;25(6):914–925. doi:10.1016/j.joca.2016.11.004.
   PubMed Web of Science ®Google Scholar
• Gamer LW, Xiang L, Rosen V. Formation and maturation of the murine meniscus. J Orthop Res. 2017;35(8):1683–1689. doi:10.1002/jor.23446.
   PubMed Web of Science ®Google Scholar
• Santangelo KS, Pieczarka EM, Nuovo GJ, Weisbrode SE, Bertone AL. Temporal expression and tissue distribution of interleukin-1β in two strains of guinea pigs with varying propensity for spontaneous knee osteoarthritis. Osteoarthritis And Cartilage. 2011;19(4):439–448. doi:10.1016/j.joca.2011.01.004.
   PubMed Web of Science ®Google Scholar
• Radakovich LB, Burton LH, Culver LA, Afzali MF, Marolf AJ, Olver CS, Santangelo KS. Systemic iron reduction via an iron deficient diet decreases the severity of knee cartilage lesions in the Dunkin-Hartley guinea pig model of osteoarthritis. Osteoarthritis And Cartilage. 2022;30(11):1482–1494. doi:10.1016/j.joca.2022.08.007.
   PubMed Web of Science ®Google Scholar
• Miotla Zarebska J, Chanalaris A, Driscoll C, Burleigh A, Miller RE, Malfait AM, Stott B, Vincent TL. CCL2 and CCR2 regulate pain-related behaviour and early gene expression in post-traumatic murine osteoarthritis but contribute little to chondropathy. Osteoarthritis And Cartilage. 2017;25(3):406–412. doi:10.1016/j.joca.2016.10.008.
   PubMed Web of Science ®Google Scholar
• Murphy SL, Lyden AK, Phillips K, Clauw DJ, Williams DA. Association between pain, radiographic severity, and centrally-mediated symptoms in women with knee osteoarthritis. Arthritis Care Res (Hoboken). 2011;63(11):1543–1549. doi:10.1002/acr.20583.
   PubMed Web of Science ®Google Scholar
• Lakes EH, Allen KD. Gait analysis methods for rodent models of arthritic disorders: reviews and recommendations. Osteoarthritis And Cartilage. 2016;24(11):1837–1849. doi:10.1016/j.joca.2016.03.008.
   PubMed Web of Science ®Google Scholar
• Allen KD, Adams SB, Setton LA. Evaluating intra-articular drug delivery for the treatment of osteoarthritis in a rat model. Tissue Eng Part B Rev. 2010;16(1):81–92. doi:10.1089/ten.teb.2009.0447.
   PubMed Web of Science ®Google Scholar
• Jacobs BY, Kloefkorn HE, Allen KD. Gait analysis methods for rodent models of osteoarthritis. Curr Pain Headache Rep. 2014;18(10):456. doi:10.1007/s11916-014-0456-x.
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Lambris JD. Crosstalk pathways between toll-like receptors and the complement system. Trends Immunol. 2010;31(4):154–163. doi:10.1016/j.it.2010.01.002.
   PubMed Web of Science ®Google Scholar
• Pope MR, Hoffman SM, Tomlinson S, Fleming SD. Complement regulates TLR4-mediated inflammatory responses during intestinal ischemia reperfusion. Mol Immunol. 2010;48(1–3):356–364. doi:10.1016/j.molimm.2010.07.004.
   PubMed Web of Science ®Google Scholar
• Assirelli E, Pulsatelli L, Dolzani P, Mariani E, Lisignoli G, Addimanda O, Meliconi R. Complement expression and activation in osteoarthritis joint compartments. Front Immunol. 2020;11:535010. doi:10.3389/fimmu.2020.535010.
   PubMed Web of Science ®Google Scholar
• Akhter N, Hasan A, Shenouda S, Wilson A, Kochumon S, Ali S, Tuomilehto J, Sindhu S, Ahmad R. TLR4/MyD88 -mediated CCL2 production by lipopolysaccharide (endotoxin): implications for metabolic inflammation. J Diabetes Metab Disord. 2018;17(1):77–84. doi:10.1007/s40200-018-0341-y.
   PubMed Web of Science ®Google Scholar
• Grandi FC, Baskar R, Smeriglio P, Murkherjee S, Indelli PF, Amanatullah DF, Goodman S, Chu C, Bendall S, Bhutani N. Single-cell mass cytometry reveals cross-talk between inflammation-dampening and inflammation-amplifying cells in osteoarthritic cartilage. Sci Adv. 2020;6(11):eaay5352. doi:10.1126/sciadv.aay5352.
   PubMed Web of Science ®Google Scholar
• Sebastian A, Chang JC, Mendez ME, Murugesh DK, Hatsell S, Economides AN, Christiansen BA, Loots GG. Comparative transcriptomics identifies novel genes and pathways involved in post-traumatic osteoarthritis development and progression. Int J Mol Sci. 2018;19(9):2657. doi:10.3390/ijms19092657.
   PubMed Web of Science ®Google Scholar
• Sorge RE, LaCroix-Fralish ML, Tuttle AH, Sotocinal SG, Austin JS, Ritchie J, Chanda ML, Graham AC, Topham L, Beggs S, others. Spinal cord toll-like receptor 4 mediates inflammatory and neuropathic hypersensitivity in male but not female mice. J Neurosci. 2011;31(43):15450–15454. doi:10.1523/JNEUROSCI.3859-11.2011.
   PubMed Web of Science ®Google Scholar
• Zaki S, Blaker CL, Little CB. OA foundations - experimental models of osteoarthritis. Osteoarthritis Cartilage. 2022;30(3):357–380. doi:10.1016/j.joca.2021.03.024.
   PubMed Web of Science ®Google Scholar